U.S. Court Won’t Block Maine Law Protecting Use of Contract Pharmacies for 340B Drugs
- September 26, 2025
AbbVie, Inc. and Novartis Pharmaceutical Corp. are the latest drug makers to come up short in their efforts to block a state law—in this case Maine’s—that requires pharmaceutical companies to deliver their drugs under the 340B program to an unlimited number of contract pharmacies.
ARTICLE TAGS
You must be logged in to access this content.